IRIS
CERRI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.866
AS - Asia 1.153
EU - Europa 933
SA - Sud America 167
AF - Africa 81
OC - Oceania 5
Totale 4.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.831
CN - Cina 425
SG - Singapore 282
IE - Irlanda 268
HK - Hong Kong 184
RU - Federazione Russa 140
BR - Brasile 122
DE - Germania 110
VN - Vietnam 103
IT - Italia 85
FI - Finlandia 84
FR - Francia 61
ZA - Sudafrica 60
GB - Regno Unito 46
UA - Ucraina 38
IN - India 34
CA - Canada 20
SE - Svezia 20
CZ - Repubblica Ceca 19
BD - Bangladesh 18
JP - Giappone 15
AR - Argentina 14
IQ - Iraq 13
MX - Messico 12
CO - Colombia 10
NL - Olanda 10
PK - Pakistan 10
PL - Polonia 10
AT - Austria 8
ES - Italia 8
ID - Indonesia 8
MA - Marocco 8
BE - Belgio 7
SA - Arabia Saudita 7
TR - Turchia 7
LT - Lituania 6
MU - Mauritius 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
PH - Filippine 4
VE - Venezuela 4
IL - Israele 3
KR - Corea 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EG - Egitto 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 4.205
Salva come PNG Salva come JPEG
Città #
Chandler 289
Dublin 268
Ashburn 212
Hong Kong 181
San Jose 174
Dallas 169
Singapore 141
Beijing 119
Boardman 58
Los Angeles 58
Johannesburg 56
Helsinki 54
Jacksonville 45
New York 45
Princeton 45
Lawrence 44
Lauterbourg 41
Shanghai 37
Munich 36
Ho Chi Minh City 33
Medford 33
Wilmington 30
Hanoi 29
Nanjing 23
São Paulo 23
The Dalles 20
Orem 19
Buffalo 18
Chicago 18
Moscow 18
Redondo Beach 18
Brno 16
Milan 16
Santa Clara 16
Nanchang 14
Tokyo 14
Changsha 13
Council Bluffs 13
Shenyang 13
Tianjin 12
Washington 12
Pavia 11
Rome 11
Atlanta 10
Hebei 10
Turku 10
Fairfield 9
Hangzhou 9
London 9
Warsaw 9
Chennai 8
Jiaxing 8
New Delhi 8
Nuremberg 8
Rio de Janeiro 8
Columbus 7
Denver 7
Düsseldorf 7
Seattle 7
Stockholm 7
Brooklyn 6
Brussels 6
Frankfurt am Main 6
Lahore 6
Norwalk 6
Toronto 6
Amsterdam 5
Boston 5
Da Nang 5
Guangzhou 5
Manchester 5
Montreal 5
Phoenix 5
Piscataway 5
Poplar 5
Shijiazhuang 5
Tashkent 5
Baku 4
Bogotá 4
Can Tho 4
Falls Church 4
Giessen 4
Hải Dương 4
Las Vegas 4
Mexico City 4
Mumbai 4
Ningbo 4
Woodbridge 4
Ankara 3
Campinas 3
Des Moines 3
Florence 3
Houston 3
Montevideo 3
Querétaro 3
Riyadh 3
San Francisco 3
Wuhan 3
Xi'an 3
Amman 2
Totale 2.826
Salva come PNG Salva come JPEG
Nome #
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 143
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. 128
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 127
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 124
Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. 120
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 118
Postnatal development of Central Nervous System: anomalies in the formation of cerebellum fissures 113
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 111
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 110
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 109
Cell proliferation and death in the brain of active and hibernating frogs 104
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 104
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 102
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 102
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 101
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum 101
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 97
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease 96
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 95
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease 93
The insect brain as a model to investigate the PCB effects. Changes of NOS-dependent NADPH diaphorase activity in Blattella germanica 92
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 92
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 92
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 91
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects 90
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 88
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 88
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 88
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 87
Repurposing opportunities for Parkinson’s disease therapies 85
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 84
Interactions of neurotransmitter systems during postnatal development of the rat hippocampal formation: effects of cisplatin 83
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 82
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 82
Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease 78
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 77
Potential therapeutic effects of polyphenols in Parkinson's disease: In vivo and in vitro pre-clinical studies 76
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease 64
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 59
Parkinson's Disease in Women and Men: What's the Difference? 59
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias 54
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease 53
Peripheral-central neuroimmune crosstalk in parkinson’s disease: What do patients and animal models tell us? 52
Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes 50
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 50
Role of autophagy in Parkinson’s disease 46
In vivo modeling of prodromal stage of Parkinson's disease 44
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 42
Parkinson’s disease 40
Totale 4.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.680
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 16 9 4
2021/2022189 0 1 3 0 1 5 2 11 10 0 33 123
2022/2023757 91 80 15 55 58 62 0 41 328 3 17 7
2023/2024362 54 50 14 15 27 96 20 22 6 14 28 16
2024/2025862 48 64 28 21 21 60 42 53 210 48 119 148
2025/20261.726 134 118 207 194 259 66 371 118 164 95 0 0
Totale 4.266